Apollomics Class A Stock Technical Analysis
| APLM Stock | 20.16 0.35 1.71% |
As of the 5th of March, Apollomics shows the Downside Deviation of 4.89, risk adjusted performance of 0.0906, and Mean Deviation of 4.39. Apollomics Class A technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Apollomics Class A coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Apollomics Class A is priced correctly, providing market reflects its regular price of 20.16 per share. Given that Apollomics has jensen alpha of 0.5887, we suggest you to validate Apollomics Class A's prevailing market performance to make sure the company can sustain itself at a future point.
Apollomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Apollomics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ApollomicsApollomics | Build AI portfolio with Apollomics Stock |
Apollomics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 2.0 | Buy | 1 | Odds |
Most Apollomics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Apollomics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Apollomics Class A, talking to its executives and customers, or listening to Apollomics conference calls.
Will Biotechnology sector continue expanding? Could Apollomics diversify its offerings? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apollomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (52.80) | Revenue Per Share | Quarterly Revenue Growth 2.623 | Return On Assets | Return On Equity |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Apollomics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apollomics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Apollomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Apollomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Apollomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Apollomics.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in Apollomics on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding Apollomics Class A or generate 0.0% return on investment in Apollomics over 90 days. Apollomics is related to or competes with Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. Apollomics is entity of United States. It is traded as Stock on NASDAQ exchange. More
Apollomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Apollomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Apollomics Class A upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.89 | |||
| Information Ratio | 0.1039 | |||
| Maximum Drawdown | 29.21 | |||
| Value At Risk | (9.57) | |||
| Potential Upside | 10.52 |
Apollomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apollomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Apollomics' standard deviation. In reality, there are many statistical measures that can use Apollomics historical prices to predict the future Apollomics' volatility.| Risk Adjusted Performance | 0.0906 | |||
| Jensen Alpha | 0.5887 | |||
| Total Risk Alpha | 0.5857 | |||
| Sortino Ratio | 0.1203 | |||
| Treynor Ratio | 0.402 |
Apollomics March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0906 | |||
| Market Risk Adjusted Performance | 0.412 | |||
| Mean Deviation | 4.39 | |||
| Semi Deviation | 4.42 | |||
| Downside Deviation | 4.89 | |||
| Coefficient Of Variation | 945.57 | |||
| Standard Deviation | 5.67 | |||
| Variance | 32.12 | |||
| Information Ratio | 0.1039 | |||
| Jensen Alpha | 0.5887 | |||
| Total Risk Alpha | 0.5857 | |||
| Sortino Ratio | 0.1203 | |||
| Treynor Ratio | 0.402 | |||
| Maximum Drawdown | 29.21 | |||
| Value At Risk | (9.57) | |||
| Potential Upside | 10.52 | |||
| Downside Variance | 23.95 | |||
| Semi Variance | 19.56 | |||
| Expected Short fall | (5.08) | |||
| Skewness | 0.4312 | |||
| Kurtosis | 0.8084 |
Apollomics Class A Backtested Returns
Apollomics appears to be unstable, given 3 months investment horizon. Apollomics Class A secures Sharpe Ratio (or Efficiency) of 0.0949, which signifies that the company had a 0.0949 % return per unit of risk over the last 3 months. By analyzing Apollomics' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please makes use of Apollomics' Downside Deviation of 4.89, risk adjusted performance of 0.0906, and Mean Deviation of 4.39 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Apollomics holds a performance score of 7. The firm shows a Beta (market volatility) of 1.47, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Apollomics will likely underperform. Please check Apollomics' semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Apollomics' price patterns will revert.
Auto-correlation | 0.39 |
Below average predictability
Apollomics Class A has below average predictability. Overlapping area represents the amount of predictability between Apollomics time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Apollomics Class A price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Apollomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.9 |
Apollomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Apollomics Class A Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Apollomics Class A across different markets.
About Apollomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Apollomics Class A on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Apollomics Class A based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Apollomics Class A price pattern first instead of the macroeconomic environment surrounding Apollomics Class A. By analyzing Apollomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Apollomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Apollomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 6.47 | 1.24 | 1.42 | 1.35 | Revenue Per Share | 1.1 | 0.21 | 0.25 | 0.23 |
Apollomics March 5, 2026 Technical Indicators
Most technical analysis of Apollomics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Apollomics from various momentum indicators to cycle indicators. When you analyze Apollomics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0906 | |||
| Market Risk Adjusted Performance | 0.412 | |||
| Mean Deviation | 4.39 | |||
| Semi Deviation | 4.42 | |||
| Downside Deviation | 4.89 | |||
| Coefficient Of Variation | 945.57 | |||
| Standard Deviation | 5.67 | |||
| Variance | 32.12 | |||
| Information Ratio | 0.1039 | |||
| Jensen Alpha | 0.5887 | |||
| Total Risk Alpha | 0.5857 | |||
| Sortino Ratio | 0.1203 | |||
| Treynor Ratio | 0.402 | |||
| Maximum Drawdown | 29.21 | |||
| Value At Risk | (9.57) | |||
| Potential Upside | 10.52 | |||
| Downside Variance | 23.95 | |||
| Semi Variance | 19.56 | |||
| Expected Short fall | (5.08) | |||
| Skewness | 0.4312 | |||
| Kurtosis | 0.8084 |
Apollomics March 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Apollomics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 22.52 | ||
| Daily Balance Of Power | (2.19) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 20.08 | ||
| Day Typical Price | 20.11 | ||
| Price Action Indicator | (0.10) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Biotechnology sector continue expanding? Could Apollomics diversify its offerings? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apollomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (52.80) | Revenue Per Share | Quarterly Revenue Growth 2.623 | Return On Assets | Return On Equity |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Apollomics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apollomics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Apollomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.